Philip Morris
the Following Is the View of Dr. Gio Gori of the Franklin Institute, Which We Feel Is Particularly Relevant to the Subject of in-Mouth Sampling Experiments
Fields
- Type
- REPT, REPORT, OTHER
- Area
- REIF,HELMUT/OFFICE
- Site
- E5
- Named Person
- Aubort
- Gori, G.
- Neurath
- Gori, G.
- Named Organization
- Coresta, Coresta
- Franklin Inst
- Fresenius
- Ftc, Federal Trade Commission
- Tc126
- Wg6
- Franklin Inst
- Request
- Stmn/R1-071
- Stmn/R2-038
- Document File
- 2028397492/2028397799/Missing
- Litigation
- Stmn/Produced
- Master ID
- 2028397493/7798
Related Documents:- 2028397493-7494 Wg6
- 2028397495 Index
- 2028397496-7497 Background
- 2028397498-7501 United States Patent 4,256,122 Cigarette Filter
- 2028397502-7506
- 2028397507-7513 United State Patent Office 3,490,461 Cigarette Ventilation
- 2028397514-7517 United States Patent 4,331,166 Cigarette
- 2028397518-7519
- 2028397520 Response to Reports From US Testing and Fresenius Laboratories
- 2028397521-7525 Puff Parameter Analyzer Critique
- 2028397526-7529
- 2028397530 Insertion Depth Using Ppa Low Tar Brands, Perforation 10-14 Mm
- 2028397531 Insertion Depth Normal Smoking Low Tar Brands, Perforation 10-14 Mm
- 2028397532-7545 Pitfalls in the Sensory Analysis of Smoking Behaviour
- 2028397546-7547 Recent Trends in Tobacco and Tobacco Smoke Research
- 2028397548 the Kamm - Fine Holder
- 2028397549-7554 Measurements of Lip Pressure Exerted on A Cigarette During Normal Smoking
- 2028397555-7559 United States Patent 4,627,448 Tobacco Smoke Article Holder and Method Therefor
- 2028397560-7576 Evaluation of A Modified Cigarette Holder
- 2028397577-7578 Investigations Into Smokers' Behaviour A Method to Determine the Depth of Insertion on Smoked Cigarettes
- 2028397579 Insertion Depth - Brand Data 1/0.1 Perforation at 11-13 Mm, Vent 78 Percent
- 2028397580 Insertion Depth - Brand Data 2/0.2 Perforation at 11-16 Mm, Vent 73 Percent
- 2028397581 Insertion Depth - Brand Data 4/0.4 Perforation at 10-14.5 Mm, Vent 60 Percent
- 2028397582 Insertion Depth - Brand Data 4/0.4 Perforation at 11-14 Mm, Vent 60 Percent
- 2028397583 Insertion Depth - Brand Data 5/0.5 Perforation at 10-13 Mm, Vent 45 Percent
- 2028397584 Insertion Depth - Brand Data 9/0.7 Perforation at 10-14 Mm, Vent 40 Percent
- 2028397585 Insertion Depth - Brand Data 16/1.2 Perforation at 11-13 Mm, Vent 17 Percent
- 2028397586 Insertion Depth - Brand Data 1/0.2 Perforation at 13-15 Mm, Vent = 83 Percent
- 2028397587 Insertion Depth Study on 24 Brands Average Insertion Depth 12 Mm
- 2028397588 Insertion Depth - 5 Brands 1-3 Mg Tar Perforation at 10-15 Mm, Vent 60-82 Percent
- 2028397589 Response to Aubort
- 2028397593-7603 A Critique of Dr Aubort's in-Mouth Study
- 2028397604-7614 Effect of Sampling Location on the Measurement of Smoke Concentration in A Glass Model of the Human Mouth
- 2028397615 Effect of Point of Sampling in A Glassmouth
- 2028397616 Effect of Point of Sampling in A Glassmouth
- 2028397617 Relative Human Uptake
- 2028397618-7621 Steady-State Concentration of Cotinine As A Measure of Nicotine-Intake by Smokers
- 2028397622-7632 Smoker Intake From Cigarettes in the 1-Mg Federal Trade Commission Tar Class
- 2028397633-7647 Cigarette Smoking Pharmacokinetics and Its Relationship to Smoking Behaviour
- 2028397662-7664 Development of Machine Smoking Parameters for Measurement of Cigarette Tar Yield in the United Kingdom
- 2028397665-7680 A Psychophysical Study on the Effectiveness of Cigarette Filters
- 2028397681-7685 A Paired Comparison Test Procedure for the Sensory Evaluation of Strength of Flavor and Ease of Draw of Cigarettes
- 2028397686-7736 Prediction of Secondary Vortex Flowfields Generated by An Interacting Multiple Free-Jet Configuration
- 2028397737-7740 Litigation
- 2028397741-7750 Decision
- 2028397751-7762 in the Matter of: the Corporation Philip Morris Belgium, Having Its Corporate Headquarters at 189, Chaussee De La Hulpe, Brussels 1170, R.C. Brussels No. 252.268, Plaintiff, Appearing Through Me Louis Van Bunnen and Me Jean-Pierre Van Cutsem, Attorneys. Against: the Corporation Bat Benelux-Odon Warland, Whose Corporate Headquarters Is at 38, Rue De Koninck, Brussels 1010, Defendant, Appearing Through Me Antoine Braun and Me Thierry Van Innis, Attorneys. A.C./2.290/83.
- 2028397763-7773 En Cause De: La S.A. Philip Morris Belgium, Ayant Son Siege Social Chaussee De La Hulpe, 189 A 1170 Bruxelles, R. C. Bruxelles No. 252.268, Demandresse, Comparant Par Me Louis Van Bunnen Et Me Jean-Pierre Van Cutsem, Avocats. Contre: La S.A. Bat Benelux-Odon Warland, Dont Le Siege Social Est Etabli A 1080 Bruxelles, Rue De Koninck, 38, Defenderesse, Comparant Par Me Antoine Braun Et Me Thierry Van Innis, Avocats. A.C./2.290/83.
- 2028397774-7785 En Cause De: La S.A. Philip Morris Belgium, Ayant Son Siege Social A 1170 Bruxelles, Chaussee De La Hulpe, 189, Appelants, Representee Par Maitre Louis Van Bunnen, Avocat A 1180 Bruxelles, 234 Avenue Coghen Et Par Maitre Jean-Pierre Van Cutsem, Avocat A 1000 Bruxelles, 2 Rue Brederode. Contre: La S.A. B.A.T. Benelux, Etablissement Odon Warland, Ayant Son Siege Social A Molenbeck St. Jean, Rue De Koninck, 38, R.C. Bruxelles, 8.338, Intimee, Representee Par Maitres Antoine Braun Et Thierry Van Innis, Avocats A 1200 Bruxelles, Avenue De Broqueville 116/Bte 10. Audience Publique Civile Du: 850706 R.G. No 1212/83 Arret Definitif
- 2028397786-7796 in the Suit 1. Philip Morris Gmbh, Fallstrasse 40, 8000 Munich 70, Officially Represented by Its Directors, Staffan Gunnarsson, Dr. Dietrich Flugs, Berndt Heider and Gunter Wille, and 2. The Limited Partnership of H.F. & Ph. F. Reemtsma & Co., Represented by Its General Partner, Reemtsma Cigarettenfabriken Gmbh, Which Is in Turn Represented by Its Directors, Dr. Horst Wiethuchter and Wolf Schulemann, Parkstrasse 51, 2000 Hamburg 52, the Plaintiffs, Represented in Court by: Attorneys Klaus Storch, Dr. H. Schwanhausser, Dr. H. Eichmann, Dr. B. Von Linstow, and Gerhard Barth, Mauerkircherstrasse 8, 8000 Munich 80 Versus B.A.T. Cigaretten-Fabriken Gmbh, Officially Represented by Its Directors, Dieter Von Specht and Gunter Uhe, Alsterufer 4, 2000 Hamburg 36, the Defendents, Represented in Court by: Attorneys Rainer Klaka, Dr. Michael Nieder, Guido Diemer, Dr. Christof Kruger, Delpstrasse 4, 8000 Munich 80, Concerning A Petition for An Order to Cease and Desist (Unfair Competition Law) Decision Docket No. 019149/64vi
- 2028397797-7798 Barclays
- Characteristic
- MARG, MARGINALIA
- Date Loaded
- 05 Jun 1998
- Brand
- Barclay
- UCSF Legacy ID
- lal56e00
Document Images
i < <ab1 w G-6
THE FOLLOWING IS THE VIEW OF DR. GI0 GORI OF THE FRANKLIN
INSTITUTE, WHICH WE F EL IS PART'I UL 'RLY RELEVANT TO THE
-
Tihe FTC-CORESTA methodology.was adopted for the purpose of informing
smokers about the relative safety of cigarettes. Evenithough these,
methods cannot measure actual intake, this is the meaning that their
res!ul ts have acqu i red i n the mind of the genera l i puibl i c, and i n
countless scientific publications over the last 20 years. The public
and scientists alike interpret FTC-CORESTA data as relative
predilctors of actual smoke~iintake.
The accusation is that BARCLAY deceives the smokers, who are ledlto
intakes far iin excess of BARCLAY's posted FTC yields. The a~ddiedl
implication is that other cigarettes in, the.same FTC class do no
deceive the smoker.
The accusation must therefore;be tested in free smoking individuals,
without the imposition of stressful laboratory techniques and
experimental bias. The accusation has also am iimpJ!ilcat'ion of
contiinuity,1 andl therefore it cannot be tested by measuringi momentary
experiences only, such as those that may dlerive from smoking a few
cigarettes in a laboratory setting. Any valid test must take into
consi~deratiion the hourly and daily fluctuations of behaviour,
metabolism and environment,, knowni to modify the momentary experience
of each smoker. Only a measure of intake that integrates smoking
experiences over a time of at least a few days ils a valid test of the
charge. Also, smokers smoke through their lungs., The mouth is only
a mechanical device.to dlraw the puff, but the important pharmacologic
effects of smoke occur after reaching and crossing the lung barrier.
In regard to internal smoke intake, the mouth is virtually,
irrelevant, and the true smoking experience of individuals must be
measured on the basis of inte.rnall intake.

-2-
For these fundamental reasons, we.reject:
Machine tests that presume t& determine the internal intake
experience of free smokers.,
Human tests which impose procedures that distort natural'
conditions of behaviour,, metabollism and environment in free
smokers.
Tests of whatever nature that measure only isolated and temporary
experiences in either man or machine, and that are incapable of
i'nformAngiabout the integraT or cumulative experience of each
smoker over time.
Specific criticism of the methodology of mouth sampling that have
been carried out*by our competitors and other institutes, e.g.
Fresenius, Neurath and Aubort, is as follows:
1. The procedure at best informs about momentary smoking
experiences. It is incapable of reflecting the daily and
intra-daily variations of behaviour and individual
pharmacologic demand for nicotine..
2. The procedure imposes on smokers an experimental stress that
distorts natural smoking conditions of the subjects.
3. A procedure that calls for simple mouth smoking, avoids and
ignores all the complex feedback reflexes that are generated
by various air, way chemosensory receptors, and that are
known to modulate smoking mechanics,, puffing profiles, and
ultiimatelly the inhalation dynamics of indiividual smokers..

-3-
4. The methodology ignores that individUal smokers have
personal tiiresholds of orgainoleptic satisfaction, and that
it is not permissible to ask smokers to switch toinew brands
without gross distortion of their natural smoking patterns.
5. Data, generating from the proposed procedure are subject to
large sources of variance from the uncertainties connected
with sample timing, interactions of smoke with saliva,
internal chemical conditions in, the mouth, smoke aging and
particle aggregation in relation to timing, humidity,
temperature and pH conditions in the mouthA'tself, and
selective absorption,of smoke particles in the mouth and in
the sampling devices utilized in the procedure.
6. The procediure is total'lly inadequate to measure the central'
question, namely, what is.the actual smoking experience andd
internal intake of smoke iniilndividual smokers.
Ilf the accusers wish to advance a serious proposal for testing their
thesis, we submit that only the most rigorous tests of actual smoke
intake in free smokers shouldibe utilized.
